Telesis Bio, Inc. Common Stock
TBIO
TBIO was delisted on the 27th of September, 2024.
1 hedge funds and large institutions have $178K invested in Telesis Bio, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 10 closing their positions.
90% less funds holding
Funds holding: 10 → 1 (-9)
90% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 10
91% less capital invested
Capital invested by funds: $2.05M → $178K (-$1.88M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$164K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NV
Northpond Ventures
Bethesda,
Maryland
|
-$2M |
| 2 |
Millennium Management
New York
|
-$47.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$8.96K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.23K |
| 5 |
DWS
Dynamic Wealth Strategies
Granite Bay,
California
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
1
Clear Street
New York
| $178K | +$164K | +46,600 | New |
|
|
NV
2
Northpond Ventures
Bethesda,
Maryland
| – | -$2M | -546,897 | Closed |
|
|
3
Millennium Management
New York
| – | -$47.1K | -12,911 | Closed |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$8.96K | -2,456 | Closed |
|
|
5
Bank of America
Charlotte,
North Carolina
| – | -$1.23K | -338 | Closed |
|
|
DWS
6
Dynamic Wealth Strategies
Granite Bay,
California
| – | -$1K | -138 | Closed |
|
7
JP Morgan Chase
New York
| – | -$113 | -31 | Closed |
|
8
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$84 | -23 | Closed |
|
9
BNP Paribas Financial Markets
Paris,
France
| – | -$7 | -2 | Closed |
|
10
Citigroup
New York
| – | -$4 | -1 | Closed |
|
TBIO Hedge Fund Activity: Q3 2024 in Review
1 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Telesis Bio, Inc. Common Stock (TBIO) for Q3 2024, worth a combined $178K — down 91% from $2.05M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of TBIO and 1 opened new positions — a net loss of 9 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Clear Street, opening a new position worth an estimated $164K. The largest seller was Northpond Ventures, exiting entirely with an estimated $2M sold.
- 1 institutional investor held Telesis Bio, Inc. Common Stock (TBIO) as of Q3 2024, down from 10 in Q2 2024.
- Funds reported $178K of Telesis Bio, Inc. Common Stock stock for Q3 2024, down 91% quarter-over-quarter.
- 1 fund opened new Telesis Bio, Inc. Common Stock positions in Q3 2024 and 10 closed out, a net change of -9 holders.
- The largest Telesis Bio, Inc. Common Stock buyer in Q3 2024 was Clear Street, an estimated $164K added.
- The largest Telesis Bio, Inc. Common Stock seller in Q3 2024 was Northpond Ventures, an estimated $2M sold.
Based on aggregated 13F filings for Q3 2024.